He holds a Bachelor's degree in Pharmacy from the Federal University of Ceará (2018) and completed his Master's degree in Pharmacology at the same institution (2022). He is currently pursuing a Ph.D. in Sciences with an emphasis in the subfield of Immuno-Oncology at A.C. Camargo Cancer Center, affiliated with the Antônio Prudente Foundation. During his Master's program, he developed skills in laboratory animal handling, as well as in methodologies related to inflammation and pain pharmacology, conducting his research on the evaluation of the anti-inflammatory effects of pharmaceutical formulations.His doctoral project focuses on investigating the influence of innate immune cells specifically natural killer cells and dendritic cells on the organization of the antitumor response in situ. He has experience in in vitro procedures for evaluating antitumor immune responses, multiparametric flow cytometry, and spatial analyses using immunohistochemistry and immunofluorescence. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
With the advent of the immune checkpoint blockade (ICB), immunotherapy has revolutionised the way how cancer patients have been treated over the last years. Groundbreaking advances have been achieved upon cancer patient treatment with anti-PD-1 and anti-CTLA-4. However, globally, only 30-50% of cancer patients respond partially or completely to anti-PD-1 and/or anti-CTLA-4. In clear cell …
| 1 / 1 | Ongoing scholarships in Brazil |
| Associated processes | |
CV Lattes
ORCID